Mykola Chekan

612 citations
20 papers · 484 indexed · h-index 15
Topics
Thyroid Cancer Diagnosis and Treatment (10 papers)Advanced Proteomics Techniques and Applications (4 papers)Cancer, Lipids, and Metabolism (4 papers)

In The Last Decade

Mykola Chekan

20 papers receiving 481 citations

Peers

Mykola Chekan
Comparison fields: 5 of 74
  • Molecular Biology 290
  • Endocrinology, Diabetes and Metabolism 191
  • Cancer Research 113
  • Spectroscopy 107
  • Oncology 67
Replace Mark A. Perlmutter with:
Mark A. Perlmutter United States
Chinmayi Prasanna Singapore
Richard C. Ostenson United States
Shaun Ghanny Canada
Ulrich Bonk Germany
Marco Manzoni Italy
Tomasz Tyszkiewicz Poland
Adrienne R. Hanson Australia
Miao Lu China
A. Seun Ajiboye United States
Mykola Chekan relative to Mark A. Perlmutter United States Mark A. Perlmutter's profile →
Citations per field
00.5×5.9×
Mark A. Perlmutter · 1×
Citations per year

Countries citing papers authored by Mykola Chekan

Since Specialization
Citations

This map shows the geographic impact of Mykola Chekan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mykola Chekan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mykola Chekan more than expected).

Fields of papers citing papers by Mykola Chekan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mykola Chekan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mykola Chekan. The network helps show where Mykola Chekan may publish in the future.

Co-authorship network of co-authors of Mykola Chekan

This figure shows the co-authorship network connecting the top 25 collaborators of Mykola Chekan. A scholar is included among the top collaborators of Mykola Chekan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mykola Chekan. Mykola Chekan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 25
3 4
4 18
5 18
6 26
7 25
8 28
9 21
10 8
11 28
12 34
13 23
14 43
15 46
16 45
17
HSPA2 is expressed in human tumors and correlates with clinical features in non-small cell lung carcinoma patients.
32
18 42
19 10
20
[Expression of the selected adhesive molecules (cadherin E, CD44, LGAL3 and CA50) in papillary thyroid carcinoma].
5

About Mykola Chekan

Mykola Chekan is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Spectroscopy, having authored 20 papers that have together received 484 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (10 papers), Advanced Proteomics Techniques and Applications (4 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (191 citations), Cancer Research (113 citations) and Spectroscopy (107 citations). Mykola Chekan has collaborated with scholars based in Poland, United Kingdom and Norway. Frequent co-authors include Piotr Wiland, Monika Pietrowska, Anna Wojakowska, Dariusz Lange, Dorota Ścieglińska, Joanna Polańska, Zdzisław Krawczyk, Marta Gawin, Barbara Jarząb and Łukasz Marczak. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and PROTEOMICS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026